News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Annie Guérin

Articles by Annie Guérin

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study

Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC

Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC

Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC

PFS Benefit Occurs With Trastuzumab Rezetecan in HER2+ Breast Cancer

© 2025 MJH Life Sciences^®

All rights reserved.